Edwards Lifesciences (EW) Tops Q2 EPS by 5c; offers guidance
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $90.81 -0.86%
Financial Fact:
Selling, general and administrative expenses: 229.6M
Today's EPS Names:
ELWT, CAAP, RNW, More
Financial Fact:
Selling, general and administrative expenses: 229.6M
Today's EPS Names:
ELWT, CAAP, RNW, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q2 EPS of $0.67, $0.05 better than the analyst estimate of $0.62. Revenue for the quarter came in at $1.53 billion versus the consensus estimate of $1.49 billion.
GUIDANCE:
Edwards Lifesciences sees FY2025 EPS of $2.40-$2.50, versus the consensus of $2.47.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Infleqtion raises Q2 revenue to $13.5M after contract restatement
- Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
